---
title: "Access to FDG PET-CT for Lung Cancer in Te Manawa Taki Midland Region, New Zealand"
id: "pubmed-43056627"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43056627"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43056627/"
doi: "10.26635/6965.7523"
published_at: "2026-11-20T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Access to FDG PET-CT for Lung Cancer in Te Manawa Taki Midland Region, New Zealand
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43056627
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43056627/)
- **DOI:** [10.26635/6965.7523](https://doi.org/10.26635%2F6965.7523)
- **Published At:** 2026-11-20T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The study measured access to **FDG PET-CT** among patients diagnosed with **lung cancer** from 2011–2021 in the Te Manawa Taki Midland region, using the Midland Lung Cancer Register and the New Zealand Cancer Registry. - Records were linked to the National Non-Admitted Patient Collection to identify who received PET-CT. - Logistic regression models estimated odds of PET-CT receipt, adjusting for age, gender, ethnicity, year of diagnosis, socio-economic status, cancer stage, cell type, **ECOG** status and comorbidities. - Case counts: 613 patients with stage I disease, 300 with stage II, and 3,722 with stages III–IV. - Imaging uptake: 75% of stage I patients and 68.3% of stage II patients underwent PET-CT; uptake increased over the study period. - Lower likelihood of PET-CT was observed among patients aged 80+, **Māori**, those with frailty (ECOG 2+), and patients with stage II–IV disease. - The study team found no association between PET-CT use and patient gender, socio-economic status, or comorbidity burden. - Authors concluded that **PET-CT** is standard care for early-stage lung cancer suitable for curative intent and that disparities in access for **Māori** require attention. - The source did not report details on interventions to correct disparities, nor did it report causal analyses to explain the ethnic differences in PET-CT receipt.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43056627/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056627%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43056627/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43056627/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43056627/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43056627/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43056627/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056627%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056627%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43056627/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43056627/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43056627/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43056627/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43056627/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43056627/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43056627/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/43056627/#conflict-of-interest) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43056627/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/43056627/#substances) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/43056627/#grants) Title & authors Abstract Conflict of interest statement MeSH terms Substances Grants and funding N Z Med J Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22N+Z+Med+J%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22N+Z+Med+J%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) . 2026 Nov 20;139(1646):56-67. doi: 10.26635/6965.7523. # Access to positron emission tomography combined with computed tomography in the management of lung cancer in Te Manawa Taki Midland Region of New Zealand [Ross Lawrenson](https://pubmed.ncbi.nlm.nih.gov/?term=Lawrenson+R&cauthor_id=43056627)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#full-view-affiliation-1 "Director of Medicine, School of Medicine, University of Waikato, Hamilton, New Zealand."), [Vithya Yogarajan](https://pubmed.ncbi.nlm.nih.gov/?term=Yogarajan+V&cauthor_id=43056627)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#full-view-affiliation-2 "Research Fellow, School of Medicine, University of Waikato, Hamilton, New Zealand."), [Rawiri Keenan](https://pubmed.ncbi.nlm.nih.gov/?term=Keenan+R&cauthor_id=43056627)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#full-view-affiliation-3 "Associate Professor, School of Medicine, University of Waikato, Hamilton, New Zealand."), [Chunhuan Lao](https://pubmed.ncbi.nlm.nih.gov/?term=Lao+C&cauthor_id=43056627)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#full-view-affiliation-4 "Senior Research Fellow, School of Health Equity and Innovation, University of Waikato, Hamilton, New Zealand."), [Janice Wong](https://pubmed.ncbi.nlm.nih.gov/?term=Wong+J&cauthor_id=43056627)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#full-view-affiliation-5 "Respiratory Physician, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand."), [Denise Aitken](https://pubmed.ncbi.nlm.nih.gov/?term=Aitken+D&cauthor_id=43056627)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#full-view-affiliation-6 "Respiratory Physician, Health New Zealand - Te Whatu Ora Lakes, Rotorua, New Zealand."), [George Laking](https://pubmed.ncbi.nlm.nih.gov/?term=Laking+G&cauthor_id=43056627)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#full-view-affiliation-7 "Oncologist, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland, Auckland, New Zealand."), [Lynne Chepulis](https://pubmed.ncbi.nlm.nih.gov/?term=Chepulis+L&cauthor_id=43056627)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#full-view-affiliation-8 "Associate Professor, School of Health Equity and Innovation, University of Waikato, Hamilton, New Zealand."), [Paul Conaglen](https://pubmed.ncbi.nlm.nih.gov/?term=Conaglen+P&cauthor_id=43056627)[ 9 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#full-view-affiliation-9 "Surgeon, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand."), [Charles de Groot](https://pubmed.ncbi.nlm.nih.gov/?term=de+Groot+C&cauthor_id=43056627)[ 10 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#full-view-affiliation-10 "Radiologist, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand."), [Mark Elwood](https://pubmed.ncbi.nlm.nih.gov/?term=Elwood+M&cauthor_id=43056627)[ 11 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#full-view-affiliation-11 "Professor, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.") Affiliations Expand ### Affiliations * 1 Director of Medicine, School of Medicine, University of Waikato, Hamilton, New Zealand. * 2 Research Fellow, School of Medicine, University of Waikato, Hamilton, New Zealand. * 3 Associate Professor, School of Medicine, University of Waikato, Hamilton, New Zealand. * 4 Senior Research Fellow, School of Health Equity and Innovation, University of Waikato, Hamilton, New Zealand. * 5 Respiratory Physician, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand. * 6 Respiratory Physician, Health New Zealand - Te Whatu Ora Lakes, Rotorua, New Zealand. * 7 Oncologist, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland, Auckland, New Zealand. * 8 Associate Professor, School of Health Equity and Innovation, University of Waikato, Hamilton, New Zealand. * 9 Surgeon, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand. * 10 Radiologist, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand. * 11 Professor, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand. * PMID: **43056627** * DOI: [ 10.26635/6965.7523 ](https://doi.org/10.26635/6965.7523) Item in Clipboard # Access to positron emission tomography combined with computed tomography in the management of lung cancer in Te Manawa Taki Midland Region of New Zealand Ross Lawrenson et al. N Z Med J. 2026. Show details Display options Display options Format Abstract PubMed PMID N Z Med J Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22N+Z+Med+J%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22N+Z+Med+J%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) . 2026 Nov 20;139(1646):56-67. doi: 10.26635/6965.7523. ### Authors [Ross Lawrenson](https://pubmed.ncbi.nlm.nih.gov/?term=Lawrenson+R&cauthor_id=43056627)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#short-view-affiliation-1 "Director of Medicine, School of Medicine, University of Waikato, Hamilton, New Zealand."), [Vithya Yogarajan](https://pubmed.ncbi.nlm.nih.gov/?term=Yogarajan+V&cauthor_id=43056627)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#short-view-affiliation-2 "Research Fellow, School of Medicine, University of Waikato, Hamilton, New Zealand."), [Rawiri Keenan](https://pubmed.ncbi.nlm.nih.gov/?term=Keenan+R&cauthor_id=43056627)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#short-view-affiliation-3 "Associate Professor, School of Medicine, University of Waikato, Hamilton, New Zealand."), [Chunhuan Lao](https://pubmed.ncbi.nlm.nih.gov/?term=Lao+C&cauthor_id=43056627)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#short-view-affiliation-4 "Senior Research Fellow, School of Health Equity and Innovation, University of Waikato, Hamilton, New Zealand."), [Janice Wong](https://pubmed.ncbi.nlm.nih.gov/?term=Wong+J&cauthor_id=43056627)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#short-view-affiliation-5 "Respiratory Physician, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand."), [Denise Aitken](https://pubmed.ncbi.nlm.nih.gov/?term=Aitken+D&cauthor_id=43056627)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#short-view-affiliation-6 "Respiratory Physician, Health New Zealand - Te Whatu Ora Lakes, Rotorua, New Zealand."), [George Laking](https://pubmed.ncbi.nlm.nih.gov/?term=Laking+G&cauthor_id=43056627)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#short-view-affiliation-7 "Oncologist, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland, Auckland, New Zealand."), [Lynne Chepulis](https://pubmed.ncbi.nlm.nih.gov/?term=Chepulis+L&cauthor_id=43056627)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#short-view-affiliation-8 "Associate Professor, School of Health Equity and Innovation, University of Waikato, Hamilton, New Zealand."), [Paul Conaglen](https://pubmed.ncbi.nlm.nih.gov/?term=Conaglen+P&cauthor_id=43056627)[ 9 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#short-view-affiliation-9 "Surgeon, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand."), [Charles de Groot](https://pubmed.ncbi.nlm.nih.gov/?term=de+Groot+C&cauthor_id=43056627)[ 10 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#short-view-affiliation-10 "Radiologist, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand."), [Mark Elwood](https://pubmed.ncbi.nlm.nih.gov/?term=Elwood+M&cauthor_id=43056627)[ 11 ](https://pubmed.ncbi.nlm.nih.gov/43056627/#short-view-affiliation-11 "Professor, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.") ### Affiliations * 1 Director of Medicine, School of Medicine, University of Waikato, Hamilton, New Zealand. * 2 Research Fellow, School of Medicine, University of Waikato, Hamilton, New Zealand. * 3 Associate Professor, School of Medicine, University of Waikato, Hamilton, New Zealand. * 4 Senior Research Fellow, School of Health Equity and Innovation, University of Waikato, Hamilton, New Zealand. * 5 Respiratory Physician, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand. * 6 Respiratory Physician, Health New Zealand - Te Whatu Ora Lakes, Rotorua, New Zealand. * 7 Oncologist, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland, Auckland, New Zealand. * 8 Associate Professor, School of Health Equity and Innovation, University of Waikato, Hamilton, New Zealand. * 9 Surgeon, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand. * 10 Radiologist, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand. * 11 Professor, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand. * PMID: **43056627** * DOI: [ 10.26635/6965.7523 ](https://doi.org/10.26635/6965.7523) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract **Background:** This study examines access to 18-F fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT; PET-CT) scans among lung cancer patients. **Data and methods:** Patients diagnosed with lung cancer in 2011-2021 were identified from the Midland Lung Cancer Register and the New Zealand Cancer Registry. Patients were linked to the National Non-Admitted Patient Collection to determine if they underwent PET-CT. Logistic regression was used to estimate the odds ratios of having PET-CT, adjusting for age, gender, ethnicity, year of diagnosis, socio-economic status, cancer stage, cell type, Eastern Cooperative Oncology Group (ECOG) status and comorbidities. **Results:** We identified 613 patients with stage I, 300 with stage II and 3,722 with stages III and IV lung cancer, with 75% of stage I and 68.3% of stage II undergoing PET-CT. PET-CT has become more common over time. Patients aged 80 years and over, Māori, those with frailty (ECOG 2+), and those with stages II-IV of disease were less likely to receive PET-CT. Gender, socio-economic status and comorbidities did not influence the use of PET-CT. **Conclusion:** PET-CT is a standard of care for patients with early-stage lung cancer, suitable for curative treatment. The disparity of access to PET-CT for Māori needs to be addressed. © PMA. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Mark Elwood is a sub-editor of the New Zealand Medical Journal. ## MeSH terms * Aged Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Aged%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Aged) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * Aged, 80 and over Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Aged%2C+80+and+over%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Aged%2C+80+and+over) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * Female Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Female%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Female) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * Fluorodeoxyglucose F18 Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Fluorodeoxyglucose+F18%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Fluorodeoxyglucose+F18) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * Health Services Accessibility* / statistics & numerical data Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Health+Services+Accessibility%2Fstatistics+and+numerical+data%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Health+Services+Accessibility) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * Lung Neoplasms* / diagnostic imaging Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lung+Neoplasms%2Fdiagnostic+imaging%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Lung+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * Lung Neoplasms* / epidemiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lung+Neoplasms%2Fepidemiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Lung+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * Lung Neoplasms* / pathology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lung+Neoplasms%2Fpathology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Lung+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * Male Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Male%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Male) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * Maori People Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Maori+People%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Maori+People) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056627/) * Middle Aged Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Middle+Aged%22%5BMeSH%5D&sort=date&sort_order=desc) *
## Related Clinical Research

- [Early STAT+ Results for Alterome’s KRAS Inhibitor in Pancreatic, Lung, and Colorectal Cancer](https://medichelpline.com/clinical-feed/stat-news-1-stat-early-results-for-alterome-s-kras-drug-for-pancreas-lung-and-colon-cancer.md)
- [COMMD1 in Cancer: Dual Roles, Mechanisms, and Translational Targets](https://medichelpline.com/clinical-feed/pubmed-43059391.md) (DOI: 10.3892/or.2026.9224)
- [LCatlas: Point-of-Care Prediction Tool for Immunotherapy Response in NSCLC](https://medichelpline.com/clinical-feed/medrxiv-19-lcatlas-a-point-of-care-tool-for-predicting-immunotherapy-outcomes-in-non-small.md)
- [FDA leadership void after Overton withdrawal; FDA rejects lung cancer drug and STAT ranks China’s](https://medichelpline.com/clinical-feed/stat-news-1-fda-s-search-for-a-new-leader-and-china-s-largest-drugmakers.md)
- [CLIC3 Drives Lung Cancer Growth via Intracellular Chloride and ROS Regulation](https://medichelpline.com/clinical-feed/pubmed-42604641.md) (DOI: 10.1016/j.gene.2026.150359)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.